To test whether the Dual RevCAR T-cell approach kills PD-L1- and PSCA-double positive tumor cells in vivo upon recognition of both antigens at the same time, an additional mouse experiment was conducted, consisting of five different groups with five mice each. Here, CD274 is linked to neoplasm.